National Comprehensive Cancer Network’s patient information team provides a patient and caregiver version of recently-updated, evidence-based expert consensus recommendations for vaccinating people with cancer against COVID-19.
Reynold Panettieri, vice chancellor for translational medicine and science at Rutgers University, and Stanley H. Weiss, an epidemiologist and professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health, are available to discuss the possibility…
A single dose of the Pfizer-BioNTech vaccine for individuals who previously had COVID-19 generates an immunologic response similar to that of individuals receiving the two-dose recommended sequence, according to a Cedars-Sinai study published today by the journal Nature Medicine.
One year ago, then 65-year-old Miriam Clark developed a fever, lost her appetite and had no energy. She and her daughter, Tye Clark, the administrative services manager of the Johns Hopkins University School of Medicine Division of Hospital Medicine, never could have imagined what they would end up going through before Miriam was diagnosed with COVID-19. Looking back on the year, the mother and daughter duo are thankful and now even have reason to celebrate.
An update from the ACAAI COVID-19 Vaccine Task Force on the risk of allergic reactions to COVID-19 vaccines – including the Johnson & Johnson vaccine
The COVID-19 vaccines have been described by many as the light at the end of the tunnel and the best tool we have to stop this pandemic. But along with the vaccine rollout, there have been a number of myths circulating about their safety and effectiveness. To set the record straight, Cedars-Sinai’s Newsroom talked with Priya Soni, MD, a pediatrician and an infectious disease specialist.
As more people receive the COVID-19 vaccines, more people have questions about allergic reactions. Those questions are answered in this FAQ.
Staff, patient and community COVID-19 vaccine updates from Keck Medicine of USC
ACAAI COVID-19 Task Force updates guidance for physicians and other providers related to risk of an allergic reaction from mRNA COVID-19 vaccines.
On Dec. 17, a U.S. Food and Drug Administration panel is expected to review the data on the Moderna COVID-19 vaccine, paving the way for approval. Researchers at the George Washington University led one of the 100 clinical sites testing…
B-roll available: Video shot today showing the freezers where Cedars-Sinai will store COVID-19 vaccines. Please note: There are NO vaccines in the video. The vaccines will not arrive until next month.
UNLV researcher Edwin Oh and colleagues have implemented wastewater surveillance programs to screen samples for the presence of COVID-19 and to extract the RNA from the SARS-COV-2 virus to find targets that make vaccines more effective.